GlassScriptPhysician profile
Garrett Wayne Rota
NPI 1447753678
$3,421.96
in general payments reported to CMS, 2019-2025
18 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $184 · 2021: $696 · 2022: $1,140 · 2023: $447 · 2024: $400 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,030.49 | 2021-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $486.33 | 2022-2023 | Tecnis Simplicity, Catalys System, Tecnis Iol |
| Abbvie INC. | $437.38 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Allergan, INC. | $352.33 | 2019-2021 | |
| Ivantis, INC | $214.18 | 2021 | |
| Sight Sciences, INC. | $156.46 | 2021-2024 | Omni Surgical System |
| Microsurgical Technology, INC. | $152.48 | 2022 | |
| Alexion Pharmaceuticals, INC. | $121.85 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $75.05 | 2025 | Xdemvy |
| Topcon Healthcare, INC. | $74.70 | 2025 | |
| Horizon Therapeutics Plc | $67.75 | 2021 | |
| Glaukos Corporation | $30.21 | 2024 | Idose |
| Dompe US, INC. | $27.28 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $21.91 | 2024 | Tyrvaya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $18.89 | 2023 | |
| Rayner Intraocular Lenses Limited | $18.07 | 2024 | Rayner Cataract Set 1, Rayone Spheric, Rayone Emv |
| Bausch & Lomb Americas INC. | $14.76 | 2024 | Miebo, Vyzulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Rota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.